secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Essence Corp (BIOE)
CIK:        0001723059
Form:       8-K/A
Filed at:   2026-05-19T20:01:25+00:00
Accession:  0001213900-26-058985
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio Essence acquires MediFlow AI software for $3.5M in stock; closes share assignments to three individuals
--------------------------------------------------------------------------------

- Acquired MediFlow AI (formerly AcuVital) from Zhituo Software for $3,500,000 in restricted common stock.
- Board approved issuance of 7,000,000 shares at $0.50/share based on five-day trading average.
- Shares assigned to three Zhituo principals: Dangwei Zhu (3.5M), Jiahui Zhang (1.75M), Xiaoquiang Cai (1.75M).
- Assignments executed May 9, 2026; share issuances deemed effective May 19, 2026, closing the deal.
- No prior material relationship existed between Bio Essence and Zhituo or the assignees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723059/000121390026058985/0001213900-26-058985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723059/000121390026058985/ea0291489-8ka1_bioessen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-058985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer